Table 5 Survival rate of patients with gastric cancer in different tumor sites during 2002–2003 in Shanghai, China
From: The survival and the long-term trends of patients with gastric cancer in Shanghai, China
Tumor sites | Sex | N | Observed survival rate [% (95% CI)] | Relative survival rate [% (95% CI)] | Median survival (years) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 year | 2 years | 3 years | 4 years | 5 years | 1 year | 2 years | 3 years | 4 years | 5 years | ||||
C16.0 Cardia | Male | 1005 | 49 (46–52) | 33 (30–36) | 24 (21–27) | 20 (18–23) | 18 (16–21) | 52 (49–55) | 37 (34–40) | 30 (27–33) | 28 (25–31) | 29 (26–32) | 1.0 |
Female | 366 | 53 (48–58) | 34 (29–39) | 26 (22–31) | 23 (19–28) | 21 (17–26) | 57 (52–62) | 39 (34–44) | 32 (27–37) | 30 (25–35) | 29 (24–34) | 1.1 | |
C16.1 Fundus | Male | 119 | 53 (44–62) | 43 (34–52) | 38 (29–47) | 31 (23–40) | 29 (21–38) | 55 (45–64) | 47 (38–56) | 44 (35–53) | 40 (31–50) | 41 (32–51) | 1.3 |
Female | 52 | 67 (52–79) | 53 (39–67) | 47 (33–61) | 45 (31–59) | 43 (30–57) | 70 (55–81) | 58 (43–71) | 54 (40–68) | 55 (41–70) | 57 (43–71) | 2.5 | |
C16.2 Body | Male | 536 | 55 (51–59) | 39 (35–43) | 32 (28–36) | 29 (25–33) | 27 (23–31) | 57 (53–61) | 43 (39–47) | 37 (33–41) | 37 (33–41) | 38 (34–42) | 1.3 |
Female | 337 | 58 (53–63) | 45 (40–50) | 38 (33–43) | 34 (29–39) | 31 (26–36) | 60 (55–65) | 47 (42–52) | 41 (36–46) | 39 (34–44) | 37 (32–43) | 1.6 | |
C16.3 Pyloric antrum | Male | 1545 | 60 (58–62) | 44 (42–47) | 37 (35–39) | 33 (31–35) | 31 (29–33) | 64 (62–66) | 50 (48–53) | 45 (42–48) | 44 (42–47) | 45 (43–48) | 1.6 |
Female | 891 | 59 (56–62) | 46 (43–49) | 39 (36–42) | 37 (34–40) | 34 (31–37) | 63 (60–66) | 51 (48–54) | 45 (42–48) | 45 (42–48) | 45 (42–48) | 1.7 | |
C16.4 Pylorus | Male | 67 | 71 (58–81) | 55 (42–67) | 49 (37–61) | 44 (32–57) | 41 (29–54) | 77 (66–87) | 62 (50–74) | 59 (47–72) | 58 (46–70) | 59 (47–72) | 2.8 |
Female | 39 | 69 (52–82) | 59 (42–74) | 54 (38–70) | 49 (33–65) | 46 (30–62) | 73 (55–85) | 64 (47–79) | 62 (45–77) | 60 (42–74) | 62 (45–77) | 3.7 | |
C16.5 Lesser curvature | Male | 527 | 74 (70–78) | 60 (56–64) | 53 (49–57) | 50 (46–54) | 47 (43–51) | 76 (72–80) | 64 (60–68) | 60 (56–64) | 60 (56–64) | 61 (57–65) | 3.9 |
Female | 231 | 72 (66–78) | 57 (50–63) | 54 (47–61) | 50 (43–57) | 46 (39–53) | 75 (69–80) | 61 (54–67) | 59 (52–65) | 57 (51–64) | 57 (51–64) | 3.9 | |
C16.6 Greater curvature | Male | 30 | 77 (58–90) | 53 (34–71) | 40 (23–59) | 40 (23–59) | 40 (23–59) | 81 (61–92) | 59 (41–77) | 47 (28–66) | 51 (31–69) | 55 (37–75) | 2.2 |
Female | 32 | 71 (52–85) | 52 (34–70) | 48 (30–66) | 48 (30–66) | 48 (30–66) | 78 (60–91) | 58 (41–76) | 57 (38–74) | 60 (41–76) | 65 (47–81) | 2.4 | |
C16.8 Overlapping sites | Male | 222 | 48 (41–55) | 29 (23–36) | 24 (19–30) | 21 (16–27) | 20 (15–26) | 50 (43–57) | 33 (27–40) | 29 (23–35) | 28 (22–34) | 30 (24–37) | 1.0 |
Female | 114 | 61 (51–70) | 44 (35–54) | 37 (28–47) | 34 (26–44) | 32 (24–41) | 63 (54–72) | 47 (38–57) | 42 (33–52) | 41 (32–51) | 40 (31–50) | 1.6 | |
C16.9 Unspecified | Male | 2987 | 42 (40–44) | 29 (27–31) | 24 (22–26) | 21 (20–23) | 20 (19–21) | 45 (43–47) | 34 (32–36) | 30 (28–32) | 30 (28–32) | 31 (29–33) | 0.9 |
Female | 1809 | 43 (41–45) | 30 28–32) | 25 (23–27) | 23 (21–25) | 21 (19–23) | 48 (46–50) | 35 (33–37) | 31 (29–33) | 31 (29–33) | 31 (29–33) | 0.9 | |